Brazil meatpacker JBS proposes Batista brothers to be elected as board members-March 2024-www.financetom.com

Brazil meatpacker JBS proposes Batista brothers to be elected as board members

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Brazil meatpacker JBS proposes Batista brothers to be elected as board members

Mar 26, 2024 6:06 PM

SAO PAULO, March 26 (Reuters) - Brazilian meatpacker JBS

proposed shareholders on Tuesday that brothers Wesley

and Joesley Batista, which are the controlling shareholders of

the company, to be elected as board members in a meeting

scheduled for April.

JBS proposed that the brothers would fill two new chairs on

the board.

Previous page： BP's Fatal Refinery Fire in 2022 'Last in a Series of Cascading Events,' Government Report Says Next page： Novo Nordisk makes impairment loss of $816 million in Q2

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BP's Fatal Refinery Fire in 2022 'Last in a Series of Cascading Events,' Government Report Says

Jun 26, 2024

10:53 AM EDT, 06/26/2024 (MT Newswires) -- The BP (BP) refinery fire that killed two brothers in 2022 was the last in a series of cascading events that began about 24 hours before, according to the US Chemical Safety Board's final report into the incident on Monday. The naphtha release and fire at the BP-Husky Toledo Refinery in Ohio on...

Novo Nordisk makes impairment loss of $816 million in Q2

Jun 26, 2024

COPENHAGEN (Reuters) -Novo Nordisk said on Wednesday it would recognise an impairment loss of about 5.7 billion Danish crowns ($816.72 million) in the second quarter of 2024, after its CLARION-CKD phase 3 trial failed to meet its primary endpoint. The impairment loss is related to the intangible asset ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular and...

Synopsys Insider Sold Shares Worth $4,050,912, According to a Recent SEC Filing

Jun 26, 2024

10:54 AM EDT, 06/26/2024 (MT Newswires) -- Aart De Geus, Director, Executive Chair, on June 24, 2024, sold 6,747 shares in Synopsys ( SNPS ) for $4,050,912. Following the Form 4 filing with the SEC, De has control over a total of 430,260 shares of the company, with 106,983 shares held directly and 323,277 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/883241/000151773724000077/xslF345X03/edgardoc.xml Price:...

Moderna Says mRESVIA RSV Vaccine Showed 50% Efficacy After 18 Months

Jun 26, 2024

10:55 AM EDT, 06/26/2024 (MT Newswires) -- Moderna ( MRNA ) said Wednesday that its mRESVIA respiratory syncytial virus or RSV vaccine demonstrated about a 50% efficacy after 18 months based on data from a pivotal phase 2/3 trial. The trial enrolled adult patients of at least 60 years old across 22 countries, according to the company. Moderna ( MRNA...